Okay everyone, let's take a step back and breathe.
Post# of 148168
(Total Views: 500)
Posted On: 03/29/2020 11:53:13 AM
Okay everyone, let's take a step back and breathe.
Yes, the media coverage thus far is exciting.
However, Leronlimab still needs to prove effectiveness in the additional patients that have been treated, and maybe then some. While we're optimistic this will be true, until ACTUAL results are released, lets temper expectations. So far, we have 2 confirmed results. Only 2. Let's see what happens with the others. If there is bad news, this PPS will fall faster than is rose last Friday.
Who knows what the FDA might want next from Cytodyn if results are positive.
The most important thing is helping people get well or minimize the effect the virus has on patients. ANY price movement in the stock will correspond, for better or worse. This is secondary IMO. Let's get people better.
It's fun to speculate PPS targets, until we expect the targets to be hit in the time frame we want. I don't want us to be set up for disappointment in this respect. There is going to be profit taking, sell off. The blessing and malediction is: the OTC does not have a halt in place for volatility. Therefore, in a sell off the price can free fall. Conversely, the price can rise with unbridled momentum.
Most of you have already seen a 100% return, if not more. That in itself is extraordinary given the market over the past 3 weeks.
I admit, it's an exciting time for Cytodyn.
We can be hopeful with tempered expectations.
GLTA
Yes, the media coverage thus far is exciting.
However, Leronlimab still needs to prove effectiveness in the additional patients that have been treated, and maybe then some. While we're optimistic this will be true, until ACTUAL results are released, lets temper expectations. So far, we have 2 confirmed results. Only 2. Let's see what happens with the others. If there is bad news, this PPS will fall faster than is rose last Friday.
Who knows what the FDA might want next from Cytodyn if results are positive.
The most important thing is helping people get well or minimize the effect the virus has on patients. ANY price movement in the stock will correspond, for better or worse. This is secondary IMO. Let's get people better.
It's fun to speculate PPS targets, until we expect the targets to be hit in the time frame we want. I don't want us to be set up for disappointment in this respect. There is going to be profit taking, sell off. The blessing and malediction is: the OTC does not have a halt in place for volatility. Therefore, in a sell off the price can free fall. Conversely, the price can rise with unbridled momentum.
Most of you have already seen a 100% return, if not more. That in itself is extraordinary given the market over the past 3 weeks.
I admit, it's an exciting time for Cytodyn.
We can be hopeful with tempered expectations.
GLTA
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼